Welcome to Gaspard Pardon (EPFL), head of the Bioengineering and Technology Platform (BET) at the AGORA-Pôle de Recherche sur le Cancer

Date de publication


The BET Platform will contribute directly to realizing the vision for AGORA as a place that fosters cross-disciplinary interactions and cutting-edge innovation, with the ultimate goal of benefitting cancer patients more rapidly and efficiently.

Read the interview here